
    
      The expected duration of subject participation, including Screening of up to 29 days,
      Treatment Periods of 6 days and 11 days each with a Washout period of minimum of 7 days in
      between periods, Follow-up period of 6 days, and end-of-study-period of 10-14 days after last
      sotagliflozin dose, is approximately 66 days.
    
  